BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15686160)

  • 21. Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F.
    Livingston SE; Simonetti JP; Bulkow LR; Homan CE; Snowball MM; Cagle HH; Negus SE; McMahon BJ
    Gastroenterology; 2007 Nov; 133(5):1452-7. PubMed ID: 17920063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B genotypes and response to adefovir treatment in patients with HBV chronic infection.
    Scotto G; Fazio V
    J Infect; 2010 May; 60(5):399-401. PubMed ID: 20226208
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical examinations based on nucleic acids of hepatitis viruses].
    Tanaka Y; Mizokami M
    Rinsho Byori; 2006 Nov; 54(11):1164-71. PubMed ID: 17240839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of antiviral therapy in the management of hepatocellular carcinoma.
    Guan YS; He Q
    Anticancer Drugs; 2013 Apr; 24(4):337-43. PubMed ID: 23388161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of chronic hepatitis B.
    Massoumi H; Martin P; Tan HH
    Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):642-50. PubMed ID: 21602690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genotyping and molecular characterization of hepatitis B virus in liver disease patients in Kenya.
    Ochwoto M; Chauhan R; Gopalakrishnan D; Chen CY; Ng'ang'a Z; Okoth F; Kioko H; Kimotho J; Kaiguri P; Kramvis A
    Infect Genet Evol; 2013 Dec; 20():103-10. PubMed ID: 23978387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aboriginal Taiwanese hepatitis B carriers have more favorable viral factors than Han Chinese carriers.
    Nien HC; Sheu JC; Kao JH; Chou HC; Su CW; Chen CH
    J Med Virol; 2011 Aug; 83(8):1326-31. PubMed ID: 21678436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural history of chronic hepatitis B: what exactly has REVEAL revealed?
    Iloeje UH; Yang HI; Chen CJ
    Liver Int; 2012 Oct; 32(9):1333-41. PubMed ID: 22510145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis B virus infection--natural history and clinical consequences.
    Ganem D; Prince AM
    N Engl J Med; 2004 Mar; 350(11):1118-29. PubMed ID: 15014185
    [No Abstract]   [Full Text] [Related]  

  • 30. Changes in liver histology as a "surrogate" end point of antiviral therapy for chronic HBV can predict progression to liver complications.
    Hui CK; Leung N; Shek WH; Zhang HY; Luk JM; Poon RT; Lo CM; Fan ST; Lau GK;
    J Clin Gastroenterol; 2008; 42(5):533-8. PubMed ID: 18344885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The association of hepatitis B virus genotype and the basal core promoter mutation in Qidong, China].
    Jin Y; Zhu Y; Chen TY; Guo X; Zhang J; Wang JB; Chen WZ; Qian GS; Tu H
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jul; 18(7):511-5. PubMed ID: 20678441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subgenotypes of hepatitis B virus genotype C in Taiwan.
    Liu CJ; Kao JH
    J Infect Dis; 2005 Oct; 192(7):1308-9; author reply 1309. PubMed ID: 16136480
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical and molecular correlation between chronic hepatitis and hepatocellular carcinoma induced by hepatitis B virus].
    Shapiro IIa; Shabrov AV; Karev VE; Leenman EE; Kvetnoĭ IM; Tsinzerling VA; Sologub TV
    Arkh Patol; 2005; 67(2):6-10. PubMed ID: 15938110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Modern strategy in the treatment of chronic hepatitis B: progress and prospects].
    Isakov VA
    Eksp Klin Gastroenterol; 2007; (2):107-12. PubMed ID: 17539354
    [No Abstract]   [Full Text] [Related]  

  • 35. [Investigation on virus genotype in patients infected with hepatitis B virus in four cities of Guizhou].
    Ding Jj; Zhang Q; Peng L; Liu YH; Li Z; Liu SD; Hu L
    Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Nov; 27(11):977-80. PubMed ID: 17402202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma.
    Chan HL; Tse CH; Mo F; Koh J; Wong VW; Wong GL; Lam Chan S; Yeo W; Sung JJ; Mok TS
    J Clin Oncol; 2008 Jan; 26(2):177-82. PubMed ID: 18182659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A proposed, evidence-based approach to the treatment of chronic Hepatitis B.
    Han SH; Durazo FA; Saab S; Tong MJ
    J Clin Gastroenterol; 2011 Mar; 45(3):259-66. PubMed ID: 20856136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic hepatitis B and hepatocellular carcinoma.
    McClune AC; Tong MJ
    Clin Liver Dis; 2010 Aug; 14(3):461-76. PubMed ID: 20638025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural history of chronic hepatitis B REVEALed.
    Chen CJ; Yang HI
    J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC): molecular mechanisms and novel paradigms.
    Brechot C; Kremsdorf D; Soussan P; Pineau P; Dejean A; Paterlini-Brechot P; Tiollais P
    Pathol Biol (Paris); 2010 Aug; 58(4):278-87. PubMed ID: 20667665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.